Image 1 of 1
CJC-1295 (No DAC) is a synthetic research peptide consisting of a 29–amino acid sequence designed for in-vitro examination of growth-hormone–related signaling and short-duration receptor interactions. Unlike the DAC-modified variant, this formulation lacks the Drug Affinity Complex, resulting in a significantly shorter experimental half-life and distinct behavior in laboratory models.
In controlled research environments, CJC-1295 (No DAC) is evaluated for:
• Short-interval receptor pathway signaling
• Acute peptide pulse studies
• In-vitro molecular interaction modeling
• Comparative research between DAC and non-DAC structures
• Enzymatic degradation and clearance characteristics
Each sterile, sealed vial contains a high-purity lyophilized peptide manufactured for consistent performance under standard laboratory storage and handling conditions. Batch verification ensures reproducibility for research applications.
Research Disclaimer:
For laboratory, in-vitro, and developmental research use only. Not for human consumption. Not for clinical, veterinary, or diagnostic use. The statements on this page have not been evaluated by the FDA.
